ABSTRACT
Invasive pulmonary aspergillosis can occur after viral influenza infection. It is described a previously healthy 58-year-old man with influenza virus infection who later suffered pulmonary aspergillosis. His response to amphotericin B was successful. The seven similar cases reported in the literature are revised and some common features established. Early antifungal therapy should be administered to any patient with previous flu illness presenting bilateral pulmonary infiltrates without response to antibiotics, if Aspergillus is isolated from the respiratory secretions.
Subject(s)
Aspergillosis/complications , Influenza A virus , Influenza, Human/complications , Lung Diseases, Fungal/complications , Adult , Aged , Amphotericin B/therapeutic use , Antifungal Agents/therapeutic use , Aspergillosis/diagnostic imaging , Aspergillosis/drug therapy , Female , Humans , Lung Diseases, Fungal/diagnostic imaging , Lung Diseases, Fungal/drug therapy , Male , Middle Aged , Radiography, ThoracicSubject(s)
Arthritis, Reactive/complications , Hidradenitis Suppurativa/complications , Adult , Humans , MaleABSTRACT
Aneurysm of the portal vein is quite infrequent and its clinical manifestations is variable. The association between aneurysm of the extrahepatic portal vein and recurring obstructive jaundice has only been described on one occasion, one where there was also portal hypertension. One case of aneurysm of extrahepatic portal vein associated with recurring cholestasis is described. The diagnosis was performed via echography and abdominal TAC and confirmed by portal venography. There was no evidence of hepatopathy or portal hypertension. Possibly, the displacement of the biliary tract the portal vein is a contributing factor to recurring cholestasis in the present case.
Subject(s)
Aneurysm/complications , Cholestasis/complications , Portal Vein , Humans , Male , Middle Aged , RecurrenceABSTRACT
Some patients with unbalanced hepatic cirrhosis may develop a recidivant pleural leakage resulting in relevant gas interchange disorders. In the treatment of recidivant pleural leakage, evacuative thoracocentesis and pleurodesis may be used. If these procedures fail, pleurectomy or surgery may be used, although with relevant morbidity and mortality rates. Another option, used mainly for malignant leakages, is the placement of a pleuroperitoneal shunt. We present the case of a patient with recidivant pleural leakage associated to hepatic cirrhosis, in which after the failure of paracentesis and pleurodesis, a pleuroperitoneal shunt was successfully inserted. The pleuroperitoneal shunt may be a therapeutical alternative in the recidivant pleural leakage associated to cirrhosis.